Phase 2 Breast Cancer Trial, Recruiting (NCT06771609)

Phase 2 Breast Cancer Trial, Recruiting NCT06771609 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06771609 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with metastatic triple-negative breast cancer (a specific type of breast cancer that has spread to other parts of the body) with clear medical records
You have received no more than one round (course) of chemotherapy for your metastatic breast cancer
You are generally well enough to carry out basic daily activities, based on a standard health assessment done within 10 days before starting the study treatment (confirm with trial site)
You have at least one tumour that can be measured on a scan, according to standard guidelines
You have previously received certain chemotherapy drugs (such as doxorubicin, epirubicin, paclitaxel, or docetaxel) before your cancer came back, or those treatments stopped working, or your doctor has decided those treatments are not suitable for you
If you are a woman, you are not pregnant, not breastfeeding, and are willing to use reliable contraception during the trial
Your liver, kidneys, blood, and other organs are working well enough, based on blood tests done within 10 days before starting the study treatment
You are willing and able to sign a consent form to take part in the study

Who may not be able to join:

There are no additional exclusion criteria listed beyond what is described above (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06771609

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase: Phase 2

Status: Recruiting

Condition: Breast Cancer

More information: https://clinicaltrials.gov/study/NCT06771609

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with metastatic triple-negative breast cancer (a specific type of breast cancer that has spread to other parts of the body) with clear medical records
You have received no more than one round (course) of chemotherapy for your metastatic breast cancer
You are generally well enough to carry out basic daily activities, based on a standard health assessment done within 10 days before starting the study treatment (confirm with trial site)
You have at least one tumour that can be measured on a scan, according to standard guidelines
You have previously received certain chemotherapy drugs (such as doxorubicin, epirubicin, paclitaxel, or docetaxel) before your cancer came back, or those treatments stopped working, or your doctor has decided those treatments are not suitable for you
If you are a woman, you are not pregnant, not breastfeeding, and are willing to use reliable contraception during the trial
Your liver, kidneys, blood, and other organs are working well enough, based on blood tests done within 10 days before starting the study treatment
You are willing and able to sign a consent form to take part in the study

Who may not be able to join:

There are no additional exclusion criteria listed beyond what is described above (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Registry

ClinicalTrials.gov

Start date

10 September 2024

Est. completion

10 September 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-Free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov